NexGel Inc (NXGL)
3.32
+0.05
(+1.53%)
USD |
NASDAQ |
Nov 22, 16:00
3.34
+0.02
(+0.60%)
After-Hours: 20:00
NexGel Cash from Investing (Quarterly): -0.008M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -0.008M |
June 30, 2024 | -0.586M |
March 31, 2024 | -0.118M |
December 31, 2023 | -0.273M |
September 30, 2023 | 0.21M |
June 30, 2023 | 4.122M |
March 31, 2023 | 0.397M |
December 31, 2022 | 0.473M |
September 30, 2022 | -0.666M |
June 30, 2022 | -5.402M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.121M |
Date | Value |
---|---|
September 30, 2021 | -0.123M |
June 30, 2021 | 0.00 |
March 31, 2021 | -0.267M |
December 31, 2020 | -0.16M |
September 30, 2020 | -0.076M |
June 30, 2020 | -0.075M |
March 31, 2020 | -0.001M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.402M
Minimum
Jun 2022
4.122M
Maximum
Jun 2023
-0.1216M
Average
-0.0415M
Median
Cash from Investing (Quarterly) Benchmarks
The Cooper Companies Inc | -124.10M |
Staar Surgical Co | -35.24M |
OrthoPediatrics Corp | -26.77M |
Innovative Eyewear Inc | -4.987M |
Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.216M |
Cash from Financing (Quarterly) | 1.214M |
Free Cash Flow | -4.054M |
Free Cash Flow Per Share (Quarterly) | -0.1871 |
Free Cash Flow to Equity (Quarterly) | -1.551M |
Free Cash Flow to Firm (Quarterly) | -1.209M |
Free Cash Flow Yield | -19.91% |